.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
McKinsey
Mallinckrodt
Argus Health
QuintilesIMS
Colorcon
Boehringer Ingelheim
Teva
AstraZeneca
Accenture

Generated: September 24, 2017

DrugPatentWatch Database Preview

HEXADROL Drug Profile

« Back to Dashboard

Which patents cover Hexadrol, and when can generic versions of Hexadrol launch?

Hexadrol is a drug marketed by Organon Usa Inc and is included in three NDAs.

The generic ingredient in HEXADROL is dexamethasone sodium phosphate. There are thirty-nine drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the dexamethasone sodium phosphate profile page.

Summary for Tradename: HEXADROL

Patents:0
Applicants:1
NDAs:3
Bulk Api Vendors: see list67
Clinical Trials: see list7
Patent Applications: see list3,314
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:HEXADROL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc
HEXADROL
dexamethasone
ELIXIR;ORAL012674-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
HEXADROL
dexamethasone sodium phosphate
INJECTABLE;INJECTION014694-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
HEXADROL
dexamethasone
TABLET;ORAL012675-009Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
HEXADROL
dexamethasone sodium phosphate
INJECTABLE;INJECTION014694-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
HEXADROL
dexamethasone
TABLET;ORAL012675-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
HEXADROL
dexamethasone
TABLET;ORAL012675-007Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
HEXADROL
dexamethasone sodium phosphate
INJECTABLE;INJECTION014694-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
HEXADROL
dexamethasone
TABLET;ORAL012675-010Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Fuji
Mallinckrodt
Fish and Richardson
Farmers Insurance
Julphar
Queensland Health
Cerilliant
Cipla
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot